Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (4)
Filtered (4)
Filter

Filter

4 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(4) Reset
Show (4)
Cancel
Apply(4) Reset
4 entriesShowing 1–4
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.
Palladia / Toceranib · Prescription Drug · Targeted Therapy · Palladia · Dogs · After Targeted Therapy · During Targeted Therapy

Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy

Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…

Read more
Veterinarian reviewing a molecular target concept and an unbranded oral medicine with a dog caregiverNamed profile Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell TumorsRepresentative category illustration – no product packaging is shown.
Prescription Drug · Targeted Therapy · Masivet · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy

Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell Tumors

Masitinib is an oral canine TKI with an EMA veterinary authorization for a defined mast cell tumor setting; the current regional label governs eligibility and monitoring.

Read more
Veterinary team coordinating a medication schedule for a dogNamed profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.
Prescription Drug · Targeted Therapy · Stelfonta · Dogs · After Targeted Therapy · During Targeted Therapy · Published Study

Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy

Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.

Read more
Veterinarian reviewing mushroom reference materials and unbranded supplement formats with a dogNamed profile K9 4 Life Turkey Tail Mushroom Powder: Product ProfileRepresentative category illustration – no product packaging is shown.
Immune-support Supplement · Mushroom Supplement · Supplement · K9 4 Life Turkey Tail · Dogs · Long-term Management · Limited / Emerging Evidence

K9 4 Life Turkey Tail Mushroom Powder: Product Profile

K9 4 Life Turkey Tail Mushroom Powder is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.

Read more